All sites C00-96,D32-33,D42-43,D45-47,D76 1514 90.6 2.4 2.4 1.0 3.6
Mouth, pharynx C00-14 22 93.6 3.7 0.9 1.8 -
  Lip C00 2 90.0 - - 10.0 -
  Tongue C02 6 96.4 - - 3.6 -
  Mouth, other C03-06 6 96.6 - 3.4 - -
  Salivary glands C07-08 3 86.7 13.3 - - -
  Pharynx C01,C09-14 5 92.6 7.4 - - -
Digestive organs C15-26 260 83.8 1.6 6.1 2.5 5.9
  Oesophagus C15 8 90.0 - 5.0 2.5 2.5
  Stomach C16 25 89.8 1.6 0.8 1.6 6.3
  Small intestine C17 6 89.3 - 3.6 3.6 3.6
  Colon C18 86 96.5 - 1.2 0.9 1.4
  Rectum, rectosigmoid C19-20 46 95.2 - 1.3 2.6 0.9
  Anus C21 2 100.0 - - - -
  Liver C22 16 63.8 1.3 17.5 6.3 11.3
  Gallbladder, bile ducts C23-24 16 65.4 7.4 13.6 2.5 11.1
  Pancreas C25 49 63.2 4.5 15.4 4.0 13.0
  Other digestive organs C26 6 42.9 3.6 14.3 7.1 32.1
Respiratory organs C30-39 78 74.3 11.6 7.2 0.5 6.4
  Nose, sinuses C30-31 2 100.0 - - - -
  Larynx, epiglottis C32 1 100.0 - - - -
  Lung, trachea C33-34 73 74.7 12.1 6.9 0.6 5.8
  Mediastinum, pleura C38 1 20.0 - 40.0 - 40.0
Bone C40-41 3 85.7 - 7.1 - 7.1
Melanoma of the skin C43 69 99.7 - - - 0.3
Skin, non-melanoma C44 89 99.3 0.2 0.2 - 0.2
Mesothelioma C45 2 100.0 - - - -
Autonomic nervous system C47 - - - - - -
Soft tissues C48-49 12 96.6 3.4 - - -
Breast C50 497 99.3 0.2 0.2 0.1 0.2
Female genital organs C51-58 168 95.8 1.1 0.8 0.4 1.9
  Cervix uteri C53 17 100.0 - - - -
  Corpus uteri C54 88 100.0 - - - -
  Uterus, other C55,C58 1 - - 20.0 20.0 60.0
  Ovary C56 44 89.5 2.3 2.7 0.5 5.0
  Other female genital C51-52,C57 17 92.0 4.6 - 1.1 2.3
Urinary organs C64-68 61 89.5 1.6 3.3 1.0 4.6
  Kidney C64 37 87.6 - 5.4 1.1 5.9
  Bladder and urinary tract2 C65-68 24 92.6 4.1 - 0.8 2.5
Eye C69 1 71.4 14.3 - 14.3 -
Brain, central nervous system C70-72,D32-33,D42-43 52 87.6 - 6.6 0.8 5.0
Thyroid gland C73 31 94.8 4.5 - - 0.6
Other endocrine glands C74-75 2 81.8 - - - 18.2
Illdefined or unknown C76,C80 41 49.8 15.6 13.7 6.8 14.1
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 127 75.8 7.5 1.1 1.7 13.8
  Hodgkin lymphoma C81 9 97.7 2.3 - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 58 98.3 0.3 0.3 - 1.0
  Malignant immunoproliferative diseases C88 1 66.7 - - - 33.3
  Myeloma and other plasma cell tumors C90 16 50.6 6.3 6.3 5.1 31.6
  Leukaemia C91-95 28 55.1 21.0 0.7 3.6 19.6
  Myelodysplastic syndromes D46 4 9.5 23.8 - - 66.7
  Myeloproliferaitive neoplasms D45,D47 12 55.2 12.1 - 3.4 29.3
Not included above
  Carcinoma in situ of the breast D05 53 99.6 - - - 0.4
  Cervix uteri, non-invasive neoplasms 132 100.0 - - - -
  Borderline tumour of the ovary D39 17 98.8 - 1.2 - -
  Basal cell carcinoma of the skin 465 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.